Thymosin Alpha-1 (Immune)
Immunomodulating Thymosin Alpha-1 segment evaluated for systemic immune response optimization.
Open Thymosin Alpha-1 (Immune) in the 3D analyzerAnalytical specification
| Empirical formula | C129H215N33O55 |
|---|---|
| Molecular weight | 3108.3 g/mol |
| Isoelectric point (pI) | 4.10 |
| Assay purity (HPLC) | 99.60% |
| Retention time | 6.22 min |
| Peak area / height | 13900 / 1110 |
| Reference batch | TH-2026-K99 |
| Research category | Immune, Solvents & Others |
| Amino-acid sequence | S-D-A-A-V-D-T-S-S-E-I-T-T-K-D-L-K-E-K-K-E-V-V-E-E-A-E-N |
Research characteristics
NK Cell Activation
Fosters native natural killer cells
Mucosal Barrier
Strengthens respiratory membrane pathways
Viral Resistance
Checked in cellular immunity trials
Antigen Drive
Promotes optimal dendritic cell processing
Reconstitution
Use the interactive reconstitution calculator to convert vial size (mg), bacteriostatic water volume (ml) and target dose (mcg) into a syringe draw on a standard 100-unit insulin syringe. Open the dosage calculator.
Related immune, solvents & others compounds
Tuftsin
Naturally occurring tetrapeptide phagocytosis-stimulating agent evaluated for immune defense.
LL-37 (Immune Grade)
Cathelicidin immune segment researched for biofilm disruption and cellular pathogens defense.
KPV (Dermal & Immune)
Purified KPV tripeptide tailored for contact dermatitis and systemic cytokine balancing studies.
Thymopentin (Immune)
Thymopentin (TP-5) segment targeting lymphocyte maturation and cellular immune validation.
Splenopentin (SP-5)
Splenic peptide analog evaluated for T-cell subset balance and antibody optimization.
VIP Peptide
Vasoactive Intestinal Peptide studied for lung mucosal barrier preservation and vasodilation.